Health and Healthcare
Health and Healthcare Articles
Genfit SA (NASDAQ: GNFT) shot up on Monday after the company announced an agreement with Lab Corporation of America Holdings (NYSE: LH). This agreement is ultimately for Genfit’s technology to...
Published:
Eiger BioPharmaceuticals has announced disappointing results from a study of Peginterferon Lambda-1a (Lambda) in outpatients with mild and uncomplicated COVID-19.
Published:
Aquestive Therapeutics said that it had received a negative response from the FDA concerning its treatment for the management of seizure clusters.
Published:
Things aren’t looking up for Inovio Pharmaceuticals, after the FDA notified the company that it was placing a partial hold on its COVID-19 vaccine study.
Published:
These five high-conviction health care stock picks from the analysts at Jefferies all make sense for investors looking to gain exposure to a sector that should continue to do well the rest of 2020...
Published:
By a count of confirmed COVID-19 cases relative to the total size of the population, Peru is the nation hurt the most by far.
Published:
The September 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Credit Suisse has set an Outperform rating and $290 price target on Amgen shares. That target implies more than 20% upside to the stock's recent trading price.
Published:
Some small-cap companies will screen as having deep value, but many value stocks are deemed to be "cheap" because they lack any new catalysts and opportunities.
Published:
Telemedicine platform provider GoodRx entered the market with a bang on Wednesday.
Published:
AC Immune stock was absolutely crushed on Wednesday after the firm announced disappointing results from its midstage Alzheimer’s disease study.
Published:
MediciNova has announced progress in its COVID-19 vaccine prototype, which stands out from the rest as it is administered intranasally.
Published:
Lack of social distancing and mask-wearing in some parts of the country, coupled with cold weather that will drive people indoors, may cause a spike in deaths in late fall and early winter. A widely...
Published:
It is fair to ask if Illumina's stock has fallen too much on the acquisition announcement. After all, Grail could revolutionize how cancer is screened and ultimately how it is treated.
Published:
Illumina shares dipped early Monday after the company announced that it would be making a critical acquisition of Grail.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.